NCT04035473 - A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

March 27, 2019

Study Completion Date

March 27, 2019

Conditions

Solid Tumor

Interventions

DRUG

HM30181 methanesulfonate monohydrate plus oral paclitaxel capsules

"HM30181 methanesulfonate monohydrate plus oral paclitaxel capsules~Oral paclitaxel capsules"

Trial Locations (7)

Dunedin Hospital, Dunedin

Monash Medical Centre, Melbourne

Auckland City Hospital, Auckland

Wellington Regional Hospital, Wellington

Shuang Ho hospital, New Taipei City

Tri-Service General Hospital, Taipei

Lotung Poh-Ai Hospital, Yilan